Anand Jillella is an Oncology physician affiliated with Augusta University. OpenAlex indexes 205 publications with 2,349 citations (h-index 17); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1120 15th St
Augusta, GA 309120004
Telephone
706-721-2505Registry record last updated 5 Jul 2017.
Clinical trials
- Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia
Sponsor: ECOG-ACRIN Cancer Research Group
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment
- Agios Pharmaceuticals, Inc.Program year20231 payment
- Apellis Pharmaceuticals, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
61.1%Opioid Agonist61.1%Oxycodone Hcl50%Oxycodone-Acetaminophen32%Morphine Sulfate Er17%Part D<11 patientsCancer & immunology
23.8%Thalidomide Analog23.8%Pomalyst41%Revlimid35%Lenalidomide24%Part D<11 patientsDermatology
15.2%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor15.2%Acyclovir100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Academic Center Outreach to Community Practices Increases Transplant Referrals and Possibly Reduce Racial Disparities
Biology of Blood and Marrow Transplantation
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Weintraub, MD
Augusta University
Satish Rao, MD
Augusta University
Avirup Guha, MBBS
Augusta University
Satish S.C. Rao
Augusta University
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”